Research graph
References from Clinical efficacy of AI-navigated transperineal MRI-TRUS fusion biopsy for prostate cancer diagnosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2021 · External reference
Recent global patterns in prostate cancer incidence and mortality rates.
10.1016/j.eururo.2019.08.005 · 2020 · External reference
2022 update on prostate cancer epidemiology and risk factors-a systematic review.
10.1016/j.eururo.2023.04.021 · 2023 · External reference
The Lancet Commission on prostate cancer: planning for the surge in cases.
10.1016/s0140-6736(24)00651-2 · 2024 · External reference
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data.
10.1016/s2468-2667(23)00211-6 · 2023 · External reference
European association of urology position paper on the prevention of infectious complications following prostate biopsy.
10.1016/j.eururo.2020.10.019 · 2021 · External reference
Developments in optimizing transperineal prostate biopsy.
10.1097/mou.0000000000000947 · 2022 · External reference
Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.
10.1007/s00345-022-04230-w · 2023 · External reference
Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial.
10.1001/jamaoncol.2020.7589 · 2021 · External reference
A matched-pair analysis comparing systematic prostate biopsy by conventional transrectal ultrasound-guidance versus software-based predefined 3D-guidance.
10.1016/j.urology.2023.03.027 · 2023 · External reference
Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability.
10.1097/ju.0000000000000156 · 2019 · External reference
Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives.
10.1080/21681805.2019.1600581 · 2019 · External reference
National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting.
10.1111/bju.14361 · 2018 · External reference
Magnetic resonance imaging-transrectal ultrasound fusion biopsy of the prostate-an update.
10.1053/j.ro.2018.04.003 · 2018 · External reference
Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study.
10.1016/j.eururo.2018.11.023 · 2019 · External reference
3-T multiparametric MRI followed by In-Bore MR-guided biopsy for detecting clinically significant prostate cancer after prior negative transrectal ultrasound-guided biopsy.
10.2214/ajr.19.22455 · 2020 · External reference
MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature.
10.1007/s00345-018-2497-y · 2019 · External reference
Prostate cancer detection rate of manually operated and robot-assisted in-bore magnetic resonance imaging targeted biopsy.
10.1016/j.euros.2022.05.002 · 2022 · External reference
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer.
10.1016/j.eururo.2016.08.041 · 2017 · External reference
MRI/US fusion transperineal versus transrectral biopsy of prostate cancer: Outcomes and complication rates, a tertiary medical center experience in the Middle East.
10.5152/tud.2022.21248 · 2022 · External reference
Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review.
10.1016/j.eururo.2014.10.026 · 2015 · External reference
Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis.
10.1038/s41391-023-00729-4 · 2024 · External reference
Transperineal prostate biopsy: a review of technique.
10.21037/tau.2019.12.40 · 2020 · External reference
Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
10.1186/s12894-024-01473-0 · 2024 · External reference
Standardisation of prostate multiparametric MRI across a hospital network: a London experience.
10.1186/s13244-021-00990-y · 2021 · External reference
Ultra-high-field MR in prostate cancer: feasibility and potential.
10.1007/s10334-022-01013-7 · 2022 · External reference
Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.
2019 · External reference
Vector prostate biopsy: a novel magnetic resonance imaging/ultrasound image fusion transperineal biopsy technique using electromagnetic needle tracking under local anaesthesia.
10.1016/j.eururo.2022.12.007 · 2023 · External reference
Risk factors for infection and acute urinary retention following transperineal prostate biopsy.
10.1007/s11255-023-03854-0 · 2024 · External reference
Factors influencing urinary retention following freehand transperineal prostate biopsy: insights from a tertiary care center study.
10.4103/iju.iju_36_24 · 2024 · External reference
Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial.
10.1001/jamaoncol.2020.7589 · ExternalCitation · doi-reference
MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature.
10.1007/s00345-018-2497-y · ExternalCitation · doi-reference
Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.
10.1007/s00345-022-04230-w · ExternalCitation · doi-reference
Ultra-high-field MR in prostate cancer: feasibility and potential.
10.1007/s10334-022-01013-7 · ExternalCitation · doi-reference
Risk factors for infection and acute urinary retention following transperineal prostate biopsy.
10.1007/s11255-023-03854-0 · ExternalCitation · doi-reference
Prostate cancer detection rate of manually operated and robot-assisted in-bore magnetic resonance imaging targeted biopsy.
10.1016/j.euros.2022.05.002 · ExternalCitation · doi-reference
Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review.
10.1016/j.eururo.2014.10.026 · ExternalCitation · doi-reference
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer.
10.1016/j.eururo.2016.08.041 · ExternalCitation · doi-reference
Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study.
10.1016/j.eururo.2018.11.023 · ExternalCitation · doi-reference
Recent global patterns in prostate cancer incidence and mortality rates.
10.1016/j.eururo.2019.08.005 · ExternalCitation · doi-reference
European association of urology position paper on the prevention of infectious complications following prostate biopsy.
10.1016/j.eururo.2020.10.019 · ExternalCitation · doi-reference
Vector prostate biopsy: a novel magnetic resonance imaging/ultrasound image fusion transperineal biopsy technique using electromagnetic needle tracking under local anaesthesia.
10.1016/j.eururo.2022.12.007 · ExternalCitation · doi-reference
2022 update on prostate cancer epidemiology and risk factors-a systematic review.
10.1016/j.eururo.2023.04.021 · ExternalCitation · doi-reference
A matched-pair analysis comparing systematic prostate biopsy by conventional transrectal ultrasound-guidance versus software-based predefined 3D-guidance.
10.1016/j.urology.2023.03.027 · ExternalCitation · doi-reference
The Lancet Commission on prostate cancer: planning for the surge in cases.
10.1016/s0140-6736(24)00651-2 · ExternalCitation · doi-reference
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data.
10.1016/s2468-2667(23)00211-6 · ExternalCitation · doi-reference
Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis.
10.1038/s41391-023-00729-4 · ExternalCitation · doi-reference
Magnetic resonance imaging-transrectal ultrasound fusion biopsy of the prostate-an update.
10.1053/j.ro.2018.04.003 · ExternalCitation · doi-reference
Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives.
10.1080/21681805.2019.1600581 · ExternalCitation · doi-reference
Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability.
10.1097/ju.0000000000000156 · ExternalCitation · doi-reference
Developments in optimizing transperineal prostate biopsy.
10.1097/mou.0000000000000947 · ExternalCitation · doi-reference
National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting.
10.1111/bju.14361 · ExternalCitation · doi-reference
Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
10.1186/s12894-024-01473-0 · ExternalCitation · doi-reference
Standardisation of prostate multiparametric MRI across a hospital network: a London experience.
10.1186/s13244-021-00990-y · ExternalCitation · doi-reference
Transperineal prostate biopsy: a review of technique.
10.21037/tau.2019.12.40 · ExternalCitation · doi-reference
3-T multiparametric MRI followed by In-Bore MR-guided biopsy for detecting clinically significant prostate cancer after prior negative transrectal ultrasound-guided biopsy.
10.2214/ajr.19.22455 · ExternalCitation · doi-reference
Factors influencing urinary retention following freehand transperineal prostate biopsy: insights from a tertiary care center study.
10.4103/iju.iju_36_24 · ExternalCitation · doi-reference
MRI/US fusion transperineal versus transrectral biopsy of prostate cancer: Outcomes and complication rates, a tertiary medical center experience in the Middle East.
10.5152/tud.2022.21248 · ExternalCitation · doi-reference
